To investigate the biological impact of MET amplification or mutation, we have examined the effects of a MET-TKI and of a small interfering RNA (siRNA) specific for MET mRNA on cell survival and signal transduction in NSCLC cells with or without such genetic alterations of MET [12]. This evidence concerns the gene MET and non-small cell lung carcinoma.